BioCentriq Appoints Syed T. Husain as Chief Executive Officer
BioCentriq, a leading cell therapy contract development and manufacturing organization (CDMO), today announces that it has appointed Syed T. Husain as its new Chief Executive Officer (CEO), and as a member of the Board of Directors. https://mma.prnewswire.com/media/2084445/BioCentriq_Logo.jpg BioCentriq, today announce the appointment of Syed T. Husain as Chief Executive Officer and Board Member BioCentriq has […]